{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:47:21Z","timestamp":1792075641803,"version":"4.4.0"},"reference-count":106,"publisher":"China Science Publishing & Media Ltd.","issue":"6","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.3724\/abbs.2026028","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:08:37Z","timestamp":1771902517000},"page":"1223-1234","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["ATP-citrate lyase: carcinogenesis and therapeutic                     advances"],"prefix":"10.3724","volume":"58","author":[{"given":"Liting","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41586-019-1095-5","volume":"568","author":"Verschueren KHG","year":"2019","unstructured":"Verschueren KHG, Blanchet C, Felix J, Dansercoer A, De Vos D, Bloch Y, Van Beeumen J. Structure of ATP citrate lyase and the origin of citrate synthase                         in the Krebs cycle. Nature, 2019, 568: 571-575.","journal-title":"Nature"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1094-6","volume":"568","author":"Wei J","year":"2019","unstructured":"Wei J, Leit S, Kuai J, Therrien E, Rafi S, Harwood Jr HJ, DeLaBarre B. An allosteric mechanism for potent inhibition of human                         ATP-citrate lyase. Nature, 2019, 568: 566-570.","journal-title":"Nature"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2019.12.010","volume":"471","author":"Icard P","year":"2020","unstructured":"Icard P, Wu Z, Fournel L, Coquerel A, Lincet H, Alifano M. ATP citrate lyase: a central metabolic enzyme in cancer. Cancer Lett, 2020, 471: 125-134.","journal-title":"Cancer Lett"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41594-019-0351-6","volume":"27","author":"Wei X","year":"2020","unstructured":"Wei X, Schultz K, Bazilevsky GA, Vogt A, Marmorstein R. Molecular basis for acetyl-CoA production by ATP-citrate lyase. Nat Struct Mol                             Biol, 2020, 27: 33-41.","journal-title":"Nat Struct Mol                             Biol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41467-023-37986-9","volume":"14","author":"Wei X","year":"2023","unstructured":"Wei X, Schultz K, Pepper HL, Megill E, Vogt A, Snyder NW, Marmorstein R. Allosteric role of the citrate synthase homology domain of ATP                         citrate lyase. Nat Commun, 2023, 14:","journal-title":"Nat Commun"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijc.28652","volume":"135","author":"Migita T","year":"2014","unstructured":"Migita T, Okabe S, Ikeda K, Igarashi S, Sugawara S, Tomida A, Soga T. Inhibition of ATP citrate lyase induces triglyceride accumulation                         with altered fatty acid composition in cancer cells. Int J Cancer, 2014, 135: 37-47.","journal-title":"Int J Cancer"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.hbpd.2020.05.010","volume":"20","author":"Han Q","year":"2021","unstructured":"Han Q, Chen CA, Yang W, Liang D, Lv HW, Lv GS, Zong QN. ATP-citrate lyase regulates stemness and metastasis in                         hepatocellular carcinoma via the Wnt\/\u03b2-catenin signaling pathway. Hepatobiliary                             Pancreatic Dis Int, 2021, 20: 251-261.","journal-title":"Hepatobiliary                             Pancreatic Dis Int"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1101\/gad.283283.116","volume":"30","author":"Zhang C","year":"2016","unstructured":"Zhang C, Liu J, Huang G, Zhao Y, Yue X, Wu H, Li J. Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to                         inhibit lipid synthesis and tumor progression. Genes Dev, 2016, 30: 1956-1970.","journal-title":"Genes Dev"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"106933","DOI":"10.1016\/j.bioorg.2023.106933","volume":"142","author":"Liang JJ","year":"2024","unstructured":"Liang JJ, Zhou XF, Long H, Li CY, Wei J, Yu XQ, Guo ZY. Recent advance of ATP citrate lyase inhibitors for the treatment                         of cancer and related diseases. Bioorg Chem, 2024, 142:","journal-title":"Bioorg Chem"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12020-022-03124-6","volume":"78","author":"Huang SS","year":"2022","unstructured":"Huang SS, Tsai CH, Kuo CY, Li YS, Cheng SP. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects                         of sorafenib in thyroid cancer cells. Endocrine, 2022, 78: 85-94.","journal-title":"Endocrine"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","volume":"98","author":"Khwairakpam AD","year":"2020","unstructured":"Khwairakpam AD, Banik K, Girisa S, Shabnam B, Shakibaei M, Fan L, Arfuso F. The vital role of ATP citrate lyase in chronic diseases. J Mol Med, 2020, 98: 71-95.","journal-title":"J Mol Med"},{"key":"CITATION12","doi-asserted-by":"crossref","unstructured":"Corsini A, Scicchitano P. Bempedoic acid: mechanism of action.                              G                         Ital Cardiol (Rome)                          2021, 22: 9s\u201314s.","DOI":"10.1714\/3582.35671"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mito.2021.08.004","volume":"60","author":"Hu X","year":"2021","unstructured":"Hu X, Wang D, Sun L, Gao Y, Zhou D, Tong X, Li J. Disturbed mitochondrial acetylation in accordance with the                         availability of acetyl groups in hepatocellular carcinoma. Mitochondrion, 2021, 60: 150-159.","journal-title":"Mitochondrion"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1158\/1078-0432.CCR-19-1359","volume":"26","author":"Guo W","year":"2020","unstructured":"Guo W, Ma J, Yang Y, Guo S, Zhang W, Zhao T, Yi X. ATP-citrate lyase epigenetically potentiates oxidative                         phosphorylation to promote melanoma growth and adaptive resistance to MAPK                         inhibition. Clin Cancer                             Res, 2020, 26: 2725-2739.","journal-title":"Clin Cancer                             Res"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/15476286.2023.2216562","volume":"20","author":"Shen T","year":"2023","unstructured":"Shen T, Wang H, Tang B, Zhu G, Wang X. The impact of RNA binding proteins and the associated long                         non-coding RNAs in the TCA cycle on cancer pathogenesis. RNA Biol, 2023, 20: 223-234.","journal-title":"RNA Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"Mart\u00ednez-Reyes I","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and                         disease. Nat Commun, 2020, 11:","journal-title":"Nat Commun"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"12259","DOI":"10.1074\/jbc.RA118.002261","volume":"293","author":"Chen LY","year":"2018","unstructured":"Chen LY, Lotz M, Terkeltaub R, Liu-Bryan R. Modulation of matrix metabolism by ATP-citrate lyase in articular                         chondrocytes. J Biol Chem, 2018, 293: 12259-12270.","journal-title":"J Biol Chem"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41467-020-14430-w","volume":"11","author":"Martinez Calejman C","year":"2020","unstructured":"Martinez Calejman C, Trefely S, Entwisle SW, Luciano A, Jung SM, Hsiao W, Torres A. mTORC2-AKT signaling to ATP-citrate lyase drives brown                         adipogenesis and de novo lipogenesis. Nat Commun, 2020, 11:","journal-title":"Nat Commun"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2023.04.074","volume":"663","author":"Lin Y","year":"2023","unstructured":"Lin Y, Fang H, Ma C, Zhou J, Ding M, Sun H, Xu Y. ACLY-\u03b2-catenin axis modulates hepatoblastoma cell proliferation. Biochem Biophys                             Res Commun, 2023, 663: 104-112.","journal-title":"Biochem Biophys                             Res Commun"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"105393","DOI":"10.1016\/j.phrs.2020.105393","volume":"165","author":"Ascen\u00e7\u00e3o K","year":"2021","unstructured":"Ascen\u00e7\u00e3o K, Dilek N, Augsburger F, Panagaki T, Zuhra K, Szabo C. Pharmacological induction of mesenchymal-epithelial transition                         via inhibition of H2S biosynthesis and consequent suppression of ACLY                         activity in colon cancer cells. Pharmacol Res, 2021, 165:","journal-title":"Pharmacol Res"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-022-04606-1","volume":"13","author":"Zhang M","year":"2022","unstructured":"Zhang M, Peng R, Wang H, Yang Z, Zhang H, Zhang Y, Wang M. Nanog mediated by FAO\/ACLY signaling induces cellular dormancy in                         colorectal cancer cells. Cell Death Dis, 2022, 13:","journal-title":"Cell Death Dis"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2012.04.144","volume":"422","author":"Chypre M","year":"2012","unstructured":"Chypre M, Zaidi N, Smans K. ATP-citrate lyase: a mini-review. Biochem Biophys                             Res Commun, 2012, 422: 1-4.","journal-title":"Biochem Biophys                             Res Commun"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12885-022-10017-4","volume":"22","author":"Li Y","year":"2022","unstructured":"Li Y, Zhao J, Chen R, Chen S, Xu Y, Cai W. Integration of clinical and transcriptomics reveals programming                         of the lipid metabolism in gastric cancer. BMC Cancer, 2022, 22:","journal-title":"BMC Cancer"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.024","volume":"513","author":"Dai M","year":"2021","unstructured":"Dai M, Yang B, Chen J, Liu F, Zhou Y, Zhou Y, Xu Q. Nuclear-translocation of ACLY induced by obesity-related factors                         enhances pyrimidine metabolism through regulating histone acetylation in                         endometrial cancer. Cancer Lett, 2021, 513: 36-49.","journal-title":"Cancer Lett"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"e1005599","DOI":"10.1371\/journal.pgen.1005599","volume":"11","author":"Keenan MM","year":"2015","unstructured":"Keenan MM, Liu B, Tang X, Wu J, Cyr D, Stevens RD, Ilkayeva O. ACLY and ACC1 regulate hypoxia-induced apoptosis by modulating                         ETV4 via \u03b1-ketoglutarate. PLoS Genet, 2015, 11:","journal-title":"PLoS Genet"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"e03323","DOI":"10.1002\/advs.202503323","volume":"12","author":"Wen J","year":"2025","unstructured":"Wen J, Shen M, Zhao H, Liu L, Hua Q, Zhao X, Liu J. Deacetylation of ACLY mediates RNA M6A-modification of NOXA and                         promotes chemoresistance of colorectal cancer. Adv Sci, 2025, 12:","journal-title":"Adv Sci"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-023-02656-7","volume":"42","author":"Hu C","year":"2023","unstructured":"Hu C, Xin Z, Sun X, Hu Y, Zhang C, Yan R, Wang Y. Activation of ACLY by SEC63 deploys metabolic reprogramming to                         facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum                         stress. J Exp Clin                             Cancer Res, 2023, 42:","journal-title":"J Exp Clin                             Cancer Res"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/hep.31249","volume":"73","author":"Gu L","year":"2021","unstructured":"Gu L, Zhu Y, Lin X, Lu B, Zhou X, Zhou F, Zhao Q. The IKK\u03b2-USP30-ACLY axis controls lipogenesis and tumorigenesis. Hepatology, 2021, 73: 160-174.","journal-title":"Hepatology"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","volume":"13","author":"Ning Z","year":"2022","unstructured":"Ning Z, Guo X, Liu X, Lu C, Wang A, Wang X, Wang W. USP22 regulates lipidome accumulation by stabilizing PPAR\u03b3 in                         hepatocellular carcinoma. Nat Commun, 2022, 13:","journal-title":"Nat Commun"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"111707","DOI":"10.1016\/j.celrep.2022.111707","volume":"41","author":"Li Q","year":"2022","unstructured":"Li Q, Yao H, Wang Y, Wu Y, Thorne RF, Zhu Y, Wu M. circPRKAA1 activates a Ku80\/Ku70\/SREBP-1 axis driving de novo                         fatty acid synthesis in cancer cells. Cell Rep, 2022, 41:","journal-title":"Cell Rep"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","volume":"30","author":"Yang Y","year":"2022","unstructured":"Yang Y, Cai J, Yang X, Wang K, Sun K, Yang Z, Zhang L. Dysregulated m6A modification promotes lipogenesis and                         development of non-alcoholic fatty liver disease and hepatocellular                         carcinoma. Mol Ther, 2022, 30: 2342-2353.","journal-title":"Mol Ther"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"8290","DOI":"10.1073\/pnas.1601571113","volume":"113","author":"Ahmad I","year":"2016","unstructured":"Ahmad I, Mui E, Galbraith L, Patel R, Tan EH, Salji M, Rust AG. Sleeping Beauty screen reveals Pparg activation in metastatic                         prostate cancer. Proc Natl Acad Sci                             USA, 2016, 113: 8290-8295.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"44252","DOI":"10.18632\/oncotarget.10020","volume":"7","author":"Xin M","year":"2016","unstructured":"Xin M, Qiao Z, Li J, Liu J, Song S, Zhao X, Miao P. miR-22 inhibits tumor growth and metastasis by targeting ATP                         citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer                         and lung cancer. Oncotarget, 2016, 7: 44252-44265.","journal-title":"Oncotarget"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41388-020-01553-z","volume":"40","author":"Singh KB","year":"2021","unstructured":"Singh KB, Hahm ER, Kim SH, Wendell SG, Singh SV. A novel metabolic function of Myc in regulation of fatty acid                         synthesis in prostate cancer. Oncogene, 2021, 40: 592-602.","journal-title":"Oncogene"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.3390\/cancers14235900","volume":"14","author":"Makhov P","year":"2022","unstructured":"Makhov P, Fazliyeva R, Tufano A, Uzzo RG, Cai KQ, Serebriiskii I, Snyder NW. Acetyl-CoA counteracts the inhibitory effect of antiandrogens on                         androgen receptor signaling in prostate cancer cells. Cancers, 2022, 14:","journal-title":"Cancers"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"43713","DOI":"10.18632\/oncotarget.9666","volume":"7","author":"Shah S","year":"2016","unstructured":"Shah S, Carriveau WJ, Li J, Campbell SL, Kopinski PK, Lim HW, Daurio N. Targeting ACLY sensitizes castration-resistant prostate cancer                         cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. Oncotarget, 2016, 7: 43713-43730.","journal-title":"Oncotarget"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41419-022-05297-4","volume":"13","author":"Zhou F","year":"2022","unstructured":"Zhou F, Ai W, Zhang Y, Hu Q, Gan M, Wang JB, Han T. ARHGEF3 regulates the stability of ACLY to promote the                         proliferation of lung cancer. Cell Death Dis, 2022, 13:","journal-title":"Cell Death Dis"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.molcel.2013.07.002","volume":"51","author":"Lin R","year":"2013","unstructured":"Lin R, Tao R, Gao X, Li T, Zhou X, Guan KL, Xiong Y. Acetylation stabilizes ATP-Citrate lyase to promote lipid                         biosynthesis and tumor growth. Mol Cell, 2013, 51: 506-518.","journal-title":"Mol Cell"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3724\/abbs.2023084","volume":"55","author":"Lu Y","year":"2023","unstructured":"Lu Y, Tian L, Peng C, Kong J, Xiao P, Li N. ACLY-induced reprogramming of glycolytic metabolism plays an                         important role in the progression of breast cancer. Acta Biochim Biophys                             Sin, 2023, 55: 878-881.","journal-title":"Acta Biochim Biophys                             Sin"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41556-024-01372-4","volume":"26","author":"Murthy D","year":"2024","unstructured":"Murthy D, Attri KS, Shukla SK, Thakur R, Chaika NV, He C, Wang D. Cancer-associated fibroblast-derived acetate promotes pancreatic                         cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1                         axis. Nat Cell Biol, 2024, 26: 613-627.","journal-title":"Nat Cell Biol"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/HEP.0000000000000692","volume":"80","author":"Gao W","year":"2024","unstructured":"Gao W, Zhang L, Li Z, Wu T, Lang C, Mulholland MW, Zhang W. Nuclear acly protects the liver from ischemia-reperfusion injury. Hepatology, 2024, 80: 1087-1103.","journal-title":"Hepatology"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/HYPERTENSIONAHA.124.24088","volume":"82","author":"Kuwahara N","year":"2025","unstructured":"Kuwahara N, Nagao M, Shinohara M, Kaneshiro K, Emoto T, Yoshida T, Fukuda T. ACLY promotes cardiac fibrosis via the regulation of DNL and                         histone acetylation.                              Hypertension, 2025, 82: 1116-1128.","journal-title":"Hypertension"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s44161-024-00502-3","volume":"3","author":"Lazaropoulos MP","year":"2024","unstructured":"Lazaropoulos MP, Gibb AA, Chapski DJ, Nair AA, Reiter AN, Roy R, Eaton DM. Nuclear ATP-citrate lyase regulates chromatin-dependent                         activation and maintenance of the myofibroblast gene program. Nat Cardiovasc                             Res, 2024, 3: 869-882.","journal-title":"Nat Cardiovasc                             Res"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41586-024-07187-5","volume":"627","author":"Lee HG","year":"2024","unstructured":"Lee HG, Rone JM, Li Z, Akl CF, Shin SW, Lee JH, Flausino LE. Disease-associated astrocyte epigenetic memory promotes CNS                         pathology. Nature, 2024, 627: 865-872.","journal-title":"Nature"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1007\/s12035-020-02057-3","volume":"57","author":"Kagawa Y","year":"2020","unstructured":"Kagawa Y, Umaru BA, Shima H, Ito R, Zama R, Islam A, Kanno S. FABP7 regulates acetyl-CoA metabolism through the interaction                         with ACLY in the nucleus of astrocytes. Mol Neurobiol, 2020, 57: 4891-4910.","journal-title":"Mol Neurobiol"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/glia.24620","volume":"73","author":"Schneider A","year":"2025","unstructured":"Schneider A, Won S, Armstrong EA, Cooper AJ, Suresh A, Rivera R, Barrett\u2010Wilt G. The role of ATP citrate lyase in myelin formation and maintenance. Glia, 2025, 73: 105-121.","journal-title":"Glia"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"e14367","DOI":"10.1002\/advs.202414367","volume":"12","author":"Ma Y","year":"2025","unstructured":"Ma Y, Zhang Y, Yang W, Tong X, Liu S, Zhou Y, Qiu M. The nuclear localization of ACLY guards early embryo development                         through recruiting P300 and HAT1 to promote histone acetylation and                         transcription. Adv Sci, 2025, 12:","journal-title":"Adv Sci"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/nar\/gkab1300","volume":"50","author":"Wu TT","year":"2022","unstructured":"Wu TT, Jun S, Choi EJ, Sun J, Yang EB, Lee HS, Kim SY. 53BP1-ACLY-SLBP-coordinated activation of replication-dependent                         histone biogenesis maintains genomic integrity. Nucleic Acids Res, 2022, 50: 1465-1483.","journal-title":"Nucleic Acids Res"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","volume":"67","author":"Sivanand S","year":"2017","unstructured":"Sivanand S, Rhoades S, Jiang Q, Lee JV, Benci J, Zhang J, Yuan S. Nuclear acetyl-CoA production by ACLY promotes homologous                         recombination. Mol Cell, 2017, 67: 252-265.e6.","journal-title":"Mol Cell"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"114496","DOI":"10.1016\/j.celrep.2024.114496","volume":"43","author":"Etoh K","year":"2024","unstructured":"Etoh K, Araki H, Koga T, Hino Y, Kuribayashi K, Hino S, Nakao M. Citrate metabolism controls the senescent microenvironment via                         the remodeling of pro-inflammatory enhancers. Cell Rep, 2024, 43:","journal-title":"Cell Rep"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.bneo.2025.100069","volume":"2","author":"da Silva-Diz V","year":"2025","unstructured":"da Silva-Diz V, Singh A, Aleksandrova M, Kim O, Thai C, Lancho O, Renck Nunes P. A feed forward loop between ACLY and MYC supports T-ALL                         progression in vivo. Blood Neoplasia, 2025, 2:","journal-title":"Blood Neoplasia"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","volume":"15","author":"Wang Y","year":"2024","unstructured":"Wang Y, Su K, Wang C, Deng T, Liu X, Sun S, Jiang Y. Chemotherapy-induced acetylation of ACLY by NAT10 promotes its                         nuclear accumulation and acetyl-CoA production to drive chemoresistance in                         hepatocellular carcinoma. Cell Death Dis, 2024, 15:","journal-title":"Cell Death Dis"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1158\/0008-5472.CAN-19-3626","volume":"80","author":"Zheng ZQ","year":"2020","unstructured":"Zheng ZQ, Li ZX, Guan JL, Liu X, Li JY, Chen Y, Lin L. Long noncoding RNA TINCR-mediated regulation of Acetyl-CoA                         metabolism promotes nasopharyngeal carcinoma progression and chemoresistance. Cancer Res, 2020, 80: 5174-5188.","journal-title":"Cancer Res"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00018-023-04965-8","volume":"80","author":"Tian Y","year":"2023","unstructured":"Tian Y, Ma J, Wang H, Yi X, Wang H, Zhang H, Guo S. BCAT2 promotes melanoma progression by activating lipogenesis via                         the epigenetic regulation of FASN and ACLY expressions. Cell Mol Life                             Sci, 2023, 80:","journal-title":"Cell Mol Life                             Sci"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/s44318-025-00369-5","volume":"44","author":"Li W","year":"2025","unstructured":"Li W, Han J, Huang B, Xu T, Wan Y, Luo D, Kong W. SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate                         ferroptosis susceptibility via FSP1 acetylation. EMBO J, 2025, 44: 1641-1662.","journal-title":"EMBO J"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/15548627.2022.2064624","volume":"19","author":"Huang H","year":"2023","unstructured":"Huang H, Ouyang Q, Mei K, Liu T, Sun Q, Liu W, Liu R. Acetylation of SCFD1 regulates SNARE complex formation and                         autophagosome-lysosome fusion. Autophagy, 2023, 19: 189-203.","journal-title":"Autophagy"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"114249","DOI":"10.1016\/j.intimp.2025.114249","volume":"150","author":"Mao H","year":"2025","unstructured":"Mao H, Guo F, Wang C, Jiang K, Li H, Lei L. ACLY inhibitor reduced Porphyromonas gingivalis-induced                         pyroptosis by suppressing microtubules acetylation in macrophages. Int                             Immunopharmacol, 2025, 150:","journal-title":"Int                             Immunopharmacol"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.3390\/cells10112962","volume":"10","author":"Santarsiero A","year":"2021","unstructured":"Santarsiero A, Convertini P, Todisco S, Pierri CL, De Grassi A, Williams NC, Iacobazzi D. ACLY nuclear translocation in human macrophages drives                         proinflammatory gene expression by NF-\u03baB acetylation. Cells, 2021, 10:","journal-title":"Cells"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"e22418","DOI":"10.1096\/fj.202200256R","volume":"36","author":"Chen Q","year":"2022","unstructured":"Chen Q, Cui K, Zhao Z, Xu X, Liu Y, Shen Y, Chen F. LPS stimulation stabilizes HIF-1\u03b1 by enhancing HIF-1\u03b1 acetylation                         via thePARP1-SIRT1 and ACLY-Tip60 pathways in macrophages. FASEB J, 2022, 36:","journal-title":"FASEB J"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"e70081","DOI":"10.1002\/jcsm.70081","volume":"16","author":"Chen C","year":"2025","unstructured":"Chen C, Zhang B, Yang C, Wang J, He Y, Yu H, Liu J. ARC-18 improved motor performance through inhibiting                         ACLY-mediated Smad2\/3 acetylation in a model of duchenne muscular dystrophy. J Cachexia Sarcopenia                             Muscle, 2025, 16:","journal-title":"J Cachexia Sarcopenia                             Muscle"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"e2213272120","DOI":"10.1073\/pnas.2213272120","volume":"120","author":"Puccini J","year":"2023","unstructured":"Puccini J, Wei J, Tong L, Bar-Sagi D. Cytoskeletal association of ATP citrate lyase controls the                         mechanodynamics of macropinocytosis. Proc Natl Acad Sci                             USA, 2023, 120:","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"112002","DOI":"10.1016\/j.intimp.2024.112002","volume":"132","author":"Wu H","year":"2024","unstructured":"Wu H, Wang L, Kang P, Zhou X, Li W, Xia Z. The SP1\/SIRT1\/ACLY signaling axis mediates fatty acid oxidation                         in renal ischemia-reperfusion-induced renal fibrosis. Int                             Immunopharmacol, 2024, 132:","journal-title":"Int                             Immunopharmacol"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.1074\/jbc.RA119.008708","volume":"294","author":"Guo L","year":"2019","unstructured":"Guo L, Guo YY, Li BY, Peng WQ, Chang XX, Gao X, Tang QQ. Enhanced acetylation of ATP-citrate lyase promotes the                         progression of nonalcoholic fatty liver disease. J Biol Chem, 2019, 294: 11805-11816.","journal-title":"J Biol Chem"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"e18129","DOI":"10.1111\/jcmm.18129","volume":"28","author":"Zhang X","year":"2024","unstructured":"Zhang X, Xu Y, Li S, Qin Y, Zhu G, Zhang Q, Zhang Y. SIRT2-mediated deacetylation of ACLY promotes the progression of                         oesophageal squamous cell carcinoma. J Cell Mol Medi, 2024, 28:","journal-title":"J Cell Mol Medi"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/1541-7786.MCR-22-0781","volume":"21","author":"Zhang S","year":"2023","unstructured":"Zhang S, Zhang Z, Liu X, Deng Y, Zheng J, Deng J, Wang Y. LncRNA-encoded micropeptide ACLY-BP drives lipid deposition and                         cell proliferation in clear cell renal cell carcinoma via maintenance of                         ACLY acetylation. Mol Cancer                             Res, 2023, 21: 1064-1078.","journal-title":"Mol Cancer                             Res"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"906127","DOI":"10.3389\/fimmu.2022.906127","volume":"13","author":"Dominguez M","year":"2022","unstructured":"Dominguez M, Truemper V, Mota AC, Br\u00fcne B, Namgaladze D. Impact of ATP-citrate lyase catalytic activity and serine 455                         phosphorylation on histone acetylation and inflammatory responses in human                         monocytic THP-1 cells. Front Immunol, 2022, 13:","journal-title":"Front Immunol"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3892\/or.2022.8469","volume":"49","author":"Velez B","year":"2022","unstructured":"Velez B, Petrella C, DiSalvo K, Cheng K, Kravtsov R, Krasniqi D, Krucher N. Combined inhibition of ACLY and CDK4\/6 reduces cancer cell growth                         and invasion. Oncol Rep, 2022, 49:","journal-title":"Oncol Rep"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.molcel.2025.02.024","volume":"85","author":"He X","year":"2025","unstructured":"He X, Chen D, Liu G, Wu Q, Zhao H, Guo D, Jiang X. PI3K\u03b2 functions as a protein kinase to promote cellular protein                         O-GlcNAcylation and acetyl-CoA production for tumor growth. Mol Cell, 2025, 85: 1411-1425.e8.","journal-title":"Mol Cell"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"115015","DOI":"10.1016\/j.celrep.2024.115015","volume":"43","author":"Wang H","year":"2024","unstructured":"Wang H, Yi X, Wang X, Yang Y, Zhang H, Wang H, Chen J. Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by                         regulating PD-L1 in melanoma. Cell Rep, 2024, 43:","journal-title":"Cell Rep"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s43018-023-00635-7","volume":"4","author":"Wartewig T","year":"2023","unstructured":"Wartewig T, Daniels J, Schulz M, Hameister E, Joshi A, Park J, Morrish E. PD-1 instructs a tumor-suppressive metabolic program that                         restricts glycolysis and restrains AP-1 activity in T cell lymphoma. Nat Cancer, 2023, 4: 1508-1525.","journal-title":"Nat Cancer"},{"key":"CITATION71","doi-asserted-by":"publisher","first-page":"eadi2465","DOI":"10.1126\/sciadv.adi2465","volume":"9","author":"Xiang W","year":"2023","unstructured":"Xiang W, Lv H, Xing F, Sun X, Ma Y, Wu L, Lv G. Inhibition of ACLY overcomes cancer immunotherapy resistance via                         polyunsaturated fatty acids peroxidation and cGAS-STING activation. Sci Adv, 2023, 9:","journal-title":"Sci Adv"},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-025-09297-0","volume":"645","author":"Gautam J","year":"2025","unstructured":"Gautam J, Wu J, Lally JSV, McNicol JD, Fayyazi R, Ahmadi E, Oniciu DC. ACLY inhibition promotes tumour immunity and suppresses liver                         cancer. Nature, 2025, 645: 507-517.","journal-title":"Nature"},{"key":"CITATION73","doi-asserted-by":"publisher","first-page":"eadj3020","DOI":"10.1126\/science.adj3020","volume":"387","author":"Ma S","year":"2025","unstructured":"Ma S, Dahabieh MS, Mann TH, Zhao S, McDonald B, Song WS, Chung HK. Nutrient-driven histone code determines exhausted CD8+                         T cell fates. Science, 2025, 387:","journal-title":"Science"},{"key":"CITATION74","doi-asserted-by":"publisher","first-page":"e20231820","DOI":"10.1084\/jem.20231820","volume":"221","author":"Kaymak I","year":"2024","unstructured":"Kaymak I, Watson MLJ, Oswald BM, Ma S, Johnson BK, DeCamp LM, Mabvakure BM. ACLY and ACSS2 link nutrient-dependent chromatin accessibility to                         CD8 T cell effector responses. J Exp Med, 2024, 221:","journal-title":"J Exp Med"},{"key":"CITATION75","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/0008-5472.CAN-21-4052","volume":"82","author":"Chowdhury S","year":"2022","unstructured":"Chowdhury S, Kar A, Bhowmik D, Gautam A, Basak D, Sarkar I, Ghosh P. Intracellular acetyl CoA potentiates the therapeutic efficacy of                         antitumor CD8+ T cells. Cancer Res, 2022, 82: 2640-2655.","journal-title":"Cancer Res"},{"key":"CITATION76","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/cyto.a.24294","volume":"99","author":"Vaughn N","year":"2021","unstructured":"Vaughn N, Haviland DL. Acly promotes metabolic reprogramming and induction of IRF4                         during early CD8+ T cell activation. Cytometry Pt A, 2021, 99: 825-831.","journal-title":"Cytometry Pt A"},{"key":"CITATION77","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/cancers13123054","volume":"13","author":"de Goede KE","year":"2021","unstructured":"de Goede KE, Verberk SGS, Baardman J, Harber KJ, van Kooyk Y, de Winther MPJ, Schetters STT. Myeloid-Specific acly deletion alters macrophage phenotype in                         vitro and in vivo without affecting tumor growth. Cancers, 2021, 13:","journal-title":"Cancers"},{"key":"CITATION78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.07.003","author":"Zhen L","year":"2025, 82: 765\u2013783","unstructured":"Zhen L, Min M, Mo X, Zhao G, Li H, Liu M, Wan L. The GOLM1-ACLY pathway regulates macrophage-secreted EFEMP1 via                         H3K27ac modifications to drive tumor progression. J Adv Res, 2025, 82: 765\u2013783,","journal-title":"J Adv Res"},{"key":"CITATION79","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1093\/jimmun\/vkaf209","volume":"214","author":"Sohn H","year":"2025","unstructured":"Sohn H, Kolicheski A, Poursine-Laurent J, Tran J, Wang Y, Gan K, Tobin JM. ACLY promotes NK cell effector function by regulating glycolysis                         and histone acetylation. J Immunol, 2025, 214: 3100-3114.","journal-title":"J Immunol"},{"key":"CITATION80","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","volume":"34","author":"Hochrein SM","year":"2022","unstructured":"Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F, Gerecke C. The glucose transporter GLUT3 controls T helper 17 cell responses                         through glycolytic-epigenetic reprogramming. Cell Metab, 2022, 34: 516-532.e11.","journal-title":"Cell Metab"},{"key":"CITATION81","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.7150\/thno.105782","volume":"15","author":"Zhang Z","year":"2025","unstructured":"Zhang Z, Chen M, Xu Y, Wang Z, Liu Z, He C, Zhang F. A natural small molecule isoginkgetin alleviates                         hypercholesterolemia and atherosclerosis by targeting ACLY. Theranostics, 2025, 15: 4325-4344.","journal-title":"Theranostics"},{"key":"CITATION82","doi-asserted-by":"publisher","first-page":"106874","DOI":"10.1016\/j.fitote.2025.106874","volume":"187","author":"Wang Y","year":"2025","unstructured":"Wang Y, Wang P, Xu F, Zhou H, Xie X, Hou T, Luo F. Identification of a novel ACLY inhibitor proanthocyanidin B2 from                         grape seeds with lipid-lowering effect in vitro. Fitoterapia, 2025, 187:","journal-title":"Fitoterapia"},{"key":"CITATION83","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1080\/14786419.2023.2219816","volume":"38","author":"Li JL","year":"2024","unstructured":"Li JL, Jiang JY, Gu SS, Zhang L, Sun Y, Wang XH, Li DY. Identification of lignans as ATP citrate lyase (ACLY) inhibitors                         from the roots of Pouzolzia zeylanica. Nat Product                             Res, 2024, 38: 1719-1726.","journal-title":"Nat Product                             Res"},{"key":"CITATION84","doi-asserted-by":"publisher","first-page":"8714","DOI":"10.1021\/acs.jafc.1c03105","volume":"69","author":"Sun Q","year":"2021","unstructured":"Sun Q, Niu Q, Guo Y, Zhuang Y, Li X, Liu J, Li N. Regulation on citrate influx and metabolism through inhibiting                         SLC13A5 and ACLY: a novel mechanism mediating the therapeutic effects of                         curcumin on NAFLD. J Agric Food Chem, 2021, 69: 8714-8725.","journal-title":"J Agric Food Chem"},{"key":"CITATION85","doi-asserted-by":"publisher","first-page":"10747","DOI":"10.3390\/ijms231810747","volume":"23","author":"Wang P","year":"2022","unstructured":"Wang P, Hou T, Xu F, Luo F, Zhou H, Liu F, Xie X. Discovery of flavonoids as novel inhibitors of ATP citrate lyase:                         structure\u2013activity relationship and inhibition profiles. Int J Mol Sci, 2022, 23:","journal-title":"Int J Mol Sci"},{"key":"CITATION86","doi-asserted-by":"publisher","first-page":"154211","DOI":"10.1016\/j.prp.2022.154211","volume":"240","author":"Ismail A","year":"2022","unstructured":"Ismail A, Mokhlis HA, Sharaky M, Sobhy MH, Hassanein SS, Doghish AS, Salama SA. Hydroxycitric acid reverses tamoxifen resistance through                         inhibition of ATP citrate lyase. Pathol-Res Pract, 2022, 240:","journal-title":"Pathol-Res Pract"},{"key":"CITATION87","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.3390\/nu14132669","volume":"14","author":"Verrelli D","year":"2022","unstructured":"Verrelli D, Dallera L, Stendardo M, Monzani S, Pasqualato S, Giorgio M, Pallavi R. Hydroxycitric acid inhibits chronic myelogenous leukemia growth                         through activation of AMPK and mTOR pathway. Nutrients, 2022, 14:","journal-title":"Nutrients"},{"key":"CITATION88","doi-asserted-by":"publisher","first-page":"117510","DOI":"10.1016\/j.biopha.2024.117510","volume":"180","author":"Li D","year":"2024","unstructured":"Li D, Yuan X, Ma J, Lu T, Zhang J, Liu H, Zhang G. Morusin, a novel inhibitor of ACLY, induces mitochondrial                         apoptosis in hepatocellular carcinoma cells through ROS-mediated mitophagy. Biomed                             Pharmacother, 2024, 180:","journal-title":"Biomed                             Pharmacother"},{"key":"CITATION89","doi-asserted-by":"publisher","first-page":"110199","DOI":"10.1016\/j.cbi.2022.110199","volume":"367","author":"Wang P","year":"2022","unstructured":"Wang P, Peng X, Hou T, Xu F, Zhou H, Yu Y, Qiu M. Discovery and characterization of novel ATP citrate lyase                         inhibitors from natural products by a luminescence-based assay. Chem Biol                             Interact, 2022, 367:","journal-title":"Chem Biol                             Interact"},{"key":"CITATION90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOL.0000000000000565","volume":"30","author":"Burke AC","year":"2019","unstructured":"Burke AC, Telford DE, Huff MW. Bempedoic acid: effects on lipoprotein metabolism and                         atherosclerosis. Curr Opin                             Lipidol, 2019, 30: 1-9.","journal-title":"Curr Opin                             Lipidol"},{"key":"CITATION91","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"Nissen SE","year":"2023","unstructured":"Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD. Bempedoic acid and cardiovascular outcomes in statin-intolerant                         patients. N Engl J Med, 2023, 388: 1353-1364.","journal-title":"N Engl J Med"},{"key":"CITATION92","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1124\/dmd.123.001449","volume":"51","author":"Sun Q","year":"2023","unstructured":"Sun Q, Guo Y, Hu W, Zhang M, Wang S, Lei Y, Meng H. Bempedoic acid unveils therapeutic potential in non-alcoholic                         fatty liver disease: suppression of the hepatic PXR-SLC13A5\/ACLY signaling                         axis. Drug Metab                             Disposition, 2023, 51: 1628-1641.","journal-title":"Drug Metab                             Disposition"},{"key":"CITATION93","doi-asserted-by":"publisher","first-page":"100051","DOI":"10.1016\/j.crphar.2021.100051","volume":"2","author":"Sanjay KV","year":"2021","unstructured":"Sanjay KV, Vishwakarma S, Zope BR, Mane VS, Mohire S, Dhakshinamoorthy S. ATP citrate lyase inhibitor Bempedoic Acid alleviate long term                         HFD induced NASH through improvement in glycemic control, reduction of                         hepatic triglycerides & total cholesterol, modulation of inflammatory                         & fibrotic genes and improvement in NAS score. Curr Res                             Pharmacol Drug Discov, 2021, 2:","journal-title":"Curr Res                             Pharmacol Drug Discov"},{"key":"CITATION94","doi-asserted-by":"publisher","first-page":"110472","DOI":"10.1016\/j.biopha.2020.110472","volume":"130","author":"Chen P","year":"2020","unstructured":"Chen P, Li L, Wang H, Zhao J, Cheng Y, Xie J, Cao M. Omeprazole, an inhibitor of proton pump, suppresses De                         novo lipogenesis in gastric epithelial cells. Biomed                             Pharmacother, 2020, 130:","journal-title":"Biomed                             Pharmacother"},{"key":"CITATION95","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2147\/DDDT.S504814","volume":"19","author":"Liu Y","year":"2025","unstructured":"Liu Y, Yu C, Zhang Y, Xie Z, Wang Y, Qian H, Liang L. A phase I study to evaluate the safety, tolerability,                         pharmacokinetics of BGT-002, a novel ATP-citrate lyase inhibitor, in healthy                         chinese subjects. Drug Des Devel Ther, 2025, 19: 1783-1794.","journal-title":"Drug Des Devel Ther"},{"key":"CITATION96","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"Hatzivassiliou G","year":"2005","unstructured":"Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell, 2005, 8: 311-321.","journal-title":"Cancer Cell"},{"key":"CITATION97","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/bj3340113","volume":"334","author":"Pearce NJ","year":"1998","unstructured":"Pearce NJ, Yates JW, Berkhout TA, Jackson B, Tew D, Boyd H, Camilleri P. The role of ATP citrate-lyase in the metabolic regulation of                         plasma lipids. Biochem J, 1998, 334: 113-119.","journal-title":"Biochem J"},{"key":"CITATION98","doi-asserted-by":"publisher","first-page":"11235","DOI":"10.2147\/IJN.S478308","volume":"19","author":"Li R","year":"2024","unstructured":"Li R, Li Y, Song Z, Gu Y, Jiao X, Wan C, Liu T. A graphene-based lipid modulation nanoplatform for synergetic                         lipid starvation\/chemo\/photothermal therapy of oral squamous cell carcinoma. Int J Nanomedicine, 2024, 19: 11235-11255.","journal-title":"Int J Nanomedicine"},{"key":"CITATION99","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/jcmm.16235","volume":"25","author":"Zheng Y","year":"2021","unstructured":"Zheng Y, Zhou Q, Zhao C, Li J, Yu Z, Zhu Q. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress                         to induce hepatocellular carcinoma cell apoptosis via p-eIF2\u03b1\/ATF4\/CHOP axis. J Cell Mol Med, 2021, 25: 1468-1479.","journal-title":"J Cell Mol Med"},{"key":"CITATION100","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2174\/0113816128387531250713164724","volume":"32","author":"Je IG","year":"2026","unstructured":"Je IG, Park JT, Lee HJ, Im AR, Lee J, Kim KY. Cholesterol-lowering effects of BMS-303141 analogues via                         inhibition of adenosine triphosphate-citrate lyase. Curr                             Pharm Des, 2026, 32: 1124-1131.","journal-title":"Curr                             Pharm Des"},{"key":"CITATION101","doi-asserted-by":"publisher","first-page":"11976","DOI":"10.1021\/acs.nanolett.4c03433","volume":"24","author":"Yu L","year":"2024","unstructured":"Yu L, Zhou X, Liu Z, Liu H, Zhang XZ, Luo GF, Shang Z. Carrier-free nanoagent interfering with cancer-associated                         fibroblasts\u2019 metabolism to promote tumor penetration for boosted                         chemotherapy. Nano Lett, 2024, 24: 11976-11984.","journal-title":"Nano Lett"},{"key":"CITATION102","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1021\/acs.jcim.2c00345","volume":"62","author":"Zang Y","year":"2022","unstructured":"Zang Y, Tai L, Hu Y, Wang Y, Sun H, Wen X, Yuan H. Discovery of a novel macrocyclic ATP citrate lyase inhibitor. J Chem Inf Model, 2022, 62: 3123-3132.","journal-title":"J Chem Inf Model"},{"key":"CITATION103","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1080\/07391102.2020.1773314","volume":"39","author":"Jha V","year":"2021","unstructured":"Jha V, Galati S, Volpi V, Ciccone L, Minutolo F, Rizzolio F, Granchi C. Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified                         by a pharmacophore-based virtual screening study. J Biomol                             Structure Dyn, 2021, 39: 3996-4004.","journal-title":"J Biomol                             Structure Dyn"},{"key":"CITATION104","doi-asserted-by":"publisher","first-page":"117684","DOI":"10.1016\/j.ejmech.2025.117684","volume":"292","author":"Zang Y","year":"2025","unstructured":"Zang Y, Shi M, Tai L, Hu Y, Wang Y, Zheng R, Feng Z. Design, synthesis, and biological evaluation of novel macrocyclic                         derivatives as potent ATP-citrate lyase inhibitors. Eur J Med                             Chem, 2025, 292:","journal-title":"Eur J Med                             Chem"},{"key":"CITATION105","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.apsb.2022.06.011","volume":"13","author":"Xie Z","year":"2023","unstructured":"Xie Z, Zhang M, Song Q, Cheng L, Zhang X, Song G, Sun X. Development of the novel ACLY inhibitor 326E as a promising                         treatment for hypercholesterolemia. Acta Pharm Sin                             B, 2023, 13: 739-753.","journal-title":"Acta Pharm Sin                             B"},{"key":"CITATION106","doi-asserted-by":"publisher","first-page":"154732","DOI":"10.1016\/j.phymed.2023.154732","volume":"113","author":"Liu D","year":"2023","unstructured":"Liu D, Dong C, Wang F, Liu W, Jin X, Qi SL, Liu L. Active post-transcriptional regulation and ACLY-mediated                         acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula                         for lung adenocarcinoma treatment. Phytomedicine, 2023, 113:","journal-title":"Phytomedicine"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/2B16D84B150C4C9BB30138E3C19C68AE","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026028","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/2B16D84B150C4C9BB30138E3C19C68AE","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:08:49Z","timestamp":1781514529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":106,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,12]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2026028","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}